Biochemistry Unit 8 Review: RNA Transcription and Processing

RNA: The Basics

• Ribonucleic acid (RNA) consists of a single-stranded molecule made up of nucleotides
  • Each nucleotide contains a ribose sugar, a phosphate group, and one of four nitrogenous bases (adenine, guanine, cytosine, or uracil)
• RNA plays a crucial role in the central dogma of molecular biology, acting as a messenger between DNA and proteins
• Three main types of RNA exist: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA)
  • mRNA carries genetic information from DNA to ribosomes for protein synthesis
  • tRNA transports amino acids to the ribosome and ensures the correct amino acid is added to the growing polypeptide chain
  • rRNA is a structural component of ribosomes and catalyzes peptide bond formation
• RNA differs from DNA in several ways, including the presence of uracil instead of thymine, a single-stranded structure, and the sugar ribose instead of deoxyribose
• RNA can form complex secondary structures through base pairing, such as hairpin loops and stem-loops, which are essential for its function and stability

Transcription Initiation

• Transcription initiation is the first step in the process of RNA synthesis, where RNA polymerase binds to a specific DNA sequence called the promoter
• In prokaryotes, the primary RNA polymerase is called RNA polymerase holoenzyme, which consists of a core enzyme and a sigma factor
  • The sigma factor recognizes and binds to the promoter sequence, facilitating the formation of the transcription initiation complex
• Eukaryotic transcription initiation involves multiple general transcription factors (GTFs) and RNA polymerase II
  • GTFs (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH) assemble on the promoter in a stepwise manner to form the pre-initiation complex (PIC)
• The TATA box, a conserved DNA sequence located upstream of the transcription start site, is a key element in many eukaryotic promoters and is recognized by the TATA-binding protein (TBP), a subunit of TFIID
• Enhancers and silencers, distant regulatory DNA sequences, can modulate transcription initiation by interacting with transcription factors and the PIC
• Once the transcription initiation complex is formed, RNA polymerase undergoes conformational changes, leading to the separation of DNA strands and the beginning of RNA synthesis

Elongation and Termination

• Elongation is the process by which RNA polymerase extends the nascent RNA chain by adding nucleotides complementary to the DNA template strand
• RNA polymerase catalyzes the formation of a phosphodiester bond between the 3' end of the growing RNA chain and the incoming nucleotide triphosphate (NTP)
  • The energy for this reaction is provided by the hydrolysis of the high-energy phosphate bonds in the NTPs
• The elongation process continues until RNA polymerase encounters a termination signal
• In prokaryotes, termination can be either Rho-dependent or Rho-independent
  • Rho-dependent termination involves the Rho protein, which binds to the nascent RNA and causes RNA polymerase to dissociate from the DNA template
  • Rho-independent termination occurs when the nascent RNA forms a stable hairpin loop followed by a series of uracil residues, causing RNA polymerase to stall and dissociate
• Eukaryotic termination is less well-understood but involves specific termination factors and RNA processing events, such as polyadenylation
• After termination, RNA polymerase dissociates from the DNA template, and the newly synthesized RNA is released

Post-Transcriptional Modifications

• Post-transcriptional modifications are chemical changes made to the nascent RNA molecule after transcription but before translation
• These modifications can affect the stability, localization, and function of the RNA molecule
• The 5' cap is a modified guanine nucleotide added to the 5' end of eukaryotic mRNAs
  • The cap protects the mRNA from degradation and facilitates its transport to the cytoplasm and recognition by the translation machinery
• The poly(A) tail is a stretch of adenine nucleotides added to the 3' end of most eukaryotic mRNAs
  • The poly(A) tail enhances mRNA stability and translation efficiency
• RNA editing is a process by which the nucleotide sequence of an RNA molecule is altered, such as the conversion of adenosine to inosine (A-to-I editing) or cytidine to uridine (C-to-U editing)
  • RNA editing can change the amino acid sequence of the encoded protein or alter the RNA's secondary structure and function
• Methylation of specific nucleotides, such as N6-methyladenosine (m6A), can influence RNA stability, splicing, and translation
• These post-transcriptional modifications add another layer of complexity and regulation to gene expression in eukaryotes

Splicing and Alternative Splicing

• Splicing is the process by which non-coding sequences (introns) are removed from the pre-mRNA, and the remaining coding sequences (exons) are joined together to form a mature mRNA
• The spliceosome, a large ribonucleoprotein complex, catalyzes the splicing reaction
  • The spliceosome consists of five small nuclear RNAs (snRNAs) and numerous protein factors
  • It recognizes specific sequences at the intron-exon boundaries (5' and 3' splice sites) and the branch point sequence within the intron
• The splicing reaction occurs in two transesterification steps
  • First, the 2' hydroxyl group of the branch point adenosine attacks the 5' splice site, forming a lariat structure
  • Second, the 3' hydroxyl group of the upstream exon attacks the 3' splice site, joining the exons and releasing the intron lariat
• Alternative splicing is a mechanism by which different combinations of exons can be included in the mature mRNA, leading to the production of multiple protein isoforms from a single gene
  • Alternative splicing is a major source of protein diversity in eukaryotes and is tightly regulated by cis-acting regulatory elements (exonic splicing enhancers and silencers) and trans-acting factors (SR proteins and hnRNPs)
• Aberrant splicing can lead to various diseases, such as spinal muscular atrophy and certain cancers, making the splicing machinery a potential target for therapeutic intervention

RNA Processing in Eukaryotes vs. Prokaryotes

• RNA processing differs significantly between eukaryotes and prokaryotes, reflecting the differences in their gene structure and cellular organization
• In prokaryotes, transcription and translation are coupled, meaning that translation can begin while the mRNA is still being synthesized
  • This is possible because prokaryotic genes lack introns, and the mRNA does not require extensive processing before translation
• Prokaryotic mRNAs have a shorter half-life compared to eukaryotic mRNAs, as they are rapidly degraded by ribonucleases
  • This allows prokaryotes to quickly respond to changes in their environment by altering gene expression
• In eukaryotes, transcription and translation are spatially and temporally separated, with transcription occurring in the nucleus and translation in the cytoplasm
  • This separation necessitates the transport of mature mRNAs from the nucleus to the cytoplasm through nuclear pore complexes
• Eukaryotic pre-mRNAs undergo extensive processing, including 5' capping, splicing, and 3' polyadenylation, before being exported to the cytoplasm
  • These processing steps are crucial for the stability, localization, and translational efficiency of the mRNA
• Eukaryotic mRNAs have a longer half-life compared to prokaryotic mRNAs, allowing for more sustained protein production and fine-tuned regulation of gene expression
• The complexity of RNA processing in eukaryotes enables them to produce a diverse array of proteins from a relatively small number of genes, facilitating the development of complex multicellular organisms

Regulatory Mechanisms

• RNA transcription and processing are tightly regulated to ensure proper gene expression and cellular function
• Transcriptional regulation involves the binding of transcription factors to specific DNA sequences (promoters and enhancers) to activate or repress transcription
  • General transcription factors (GTFs) are required for the assembly of the pre-initiation complex and the recruitment of RNA polymerase
  • Specific transcription factors bind to regulatory elements and modulate the activity of the general transcription machinery
• Chromatin structure and epigenetic modifications, such as histone modifications and DNA methylation, can influence the accessibility of DNA to transcription factors and RNA polymerase
  • Euchromatin is associated with active transcription, while heterochromatin is associated with transcriptional repression
• Post-transcriptional regulation encompasses mechanisms that control RNA processing, stability, and translation
  • RNA-binding proteins (RBPs) can recognize specific sequences or structures in the RNA and regulate splicing, polyadenylation, and mRNA stability
  • MicroRNAs (miRNAs) are small non-coding RNAs that can base-pair with complementary sequences in mRNAs and induce their degradation or translational repression
• RNA localization is another form of post-transcriptional regulation, where specific mRNAs are transported to distinct subcellular compartments for localized translation
  • This mechanism is crucial for the establishment of cellular polarity and the spatial control of protein synthesis
• RNA turnover and degradation are essential for maintaining the proper balance of RNA species in the cell
  • Exosomes and other ribonucleases degrade RNA in a regulated manner, preventing the accumulation of aberrant or unnecessary transcripts

Applications and Research Frontiers

• Understanding the mechanisms of RNA transcription and processing has led to numerous applications in biotechnology and medicine
• RNA interference (RNAi) is a powerful tool for gene silencing that exploits the endogenous miRNA pathway
  • Small interfering RNAs (siRNAs) can be designed to target specific mRNAs for degradation, enabling the study of gene function and the development of novel therapies
• CRISPR-Cas systems, originally discovered as a prokaryotic adaptive immune mechanism, have been repurposed for genome editing and transcriptional regulation
  • CRISPR-Cas9 can be programmed with a guide RNA to introduce targeted double-strand breaks in DNA, facilitating precise genome modifications
  • CRISPR-based tools have also been developed for RNA targeting and manipulation, expanding the possibilities for RNA-based therapeutics
• RNA-based vaccines have gained significant attention, particularly in light of the COVID-19 pandemic
  • These vaccines deliver mRNA encoding a viral antigen, which is then translated by the host cell to elicit an immune response
  • RNA vaccines offer several advantages over traditional vaccines, including rapid development, scalability, and the ability to induce both humoral and cellular immunity
• RNA-based therapies, such as antisense oligonucleotides and aptamers, are being developed to treat a wide range of diseases, from genetic disorders to cancer
  • Antisense oligonucleotides can bind to complementary sequences in mRNA and modulate splicing or induce degradation
  • Aptamers are short, single-stranded oligonucleotides that can fold into specific structures and bind to target molecules with high affinity and specificity
• Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of gene expression at the individual cell level
  • This technology enables the identification of rare cell types, the characterization of cellular heterogeneity, and the reconstruction of developmental trajectories
  • scRNA-seq has applications in developmental biology, cancer research, and personalized medicine
• The field of epitranscriptomics focuses on the study of RNA modifications and their roles in gene expression and cellular function
  • Advances in high-throughput sequencing and mass spectrometry have enabled the mapping of RNA modifications across the transcriptome
  • Understanding the dynamics and functions of RNA modifications, such as m6A, could lead to new insights into disease mechanisms and potential therapeutic targets